References
Bertino JR (1982) Adjuvant chemotherapy and cancer cure. Int J Radiat Oncol Biol Phys 8: 113
Bloom HJG (1981) Pre-operative intermediate-dose radiotherapy and cystectomy for deeply invasive carcinoma of the bladder: Rationale and results. In: Oliver RTD, Hendry WF, Bloom HJG (eds) Bladder cancer — Principles of combination therapy. Butterworths, London, pp 151–174
Bloom HJG, Hendry WF, Wallace DM, Skeet RG (1982) Treatment of T3 bladder cancer: Controlled trial of pre-operative radiotherapy and radical cystectomy versus radical radiotherapy. Second report and review (for the Clinical Trials Group, Institute of Urology). Br J Urol 54: 136–151
Campbell M, Baker LH, Opipari M, Al-Sarraf M (1981) Phase II trial with cisplatin, doxorubicin, and cyclophosphamide (CAP) in the treatment of urothelial transitional cell carcinoma. Cancer Treat Rep 65: 897–899
Carter SK, Wasserman TH (1975) The chemotherapy of urologic cancer. Cancer 36: 729–747
Cummings KB, Shipley WU, Einstein AB, Cutler SJ (1979) Current concepts in the management of patients with deeply invasive bladder cancer. Semin Oncol 6: 220–228
De Jager R, Cappelaere P, Earl H, Rubens R, Stuart Harris R, Smith I, Renard J, van Glabbeke M, Mathé G (1981) Phase II clinical trial of mitoxantrone in solid tumors. NCI-EORTC Symposium on New Drugs, Abstract 39
Edsmyr F (1981) Radiotherapy in the management of bladder cancer. In: Oliver RTD, Hendry WF, Bloom HJG (eds) Bladder cancer — Principles of combination therapy. Butterworths, London, pp 139–149
EORTC Urological Group (1977) The treatment of advanced carcinoma of the bladder with a combination of Adriamycin and 5-fluorouracil. Eur J Urol 3: 276–278
Fox M (1965) The effect of cyclophosphamide on some urinary tract tumours. Br J Urol 37: 399–405
Herr HW (1980) cis-Diamminedichloride platinum II in the treatment of advanced bladder cancer. J Urol 123: 853–855
Hope-Stone HF, Blandy JP, Oliver RTD, England H (1981) Radical radiotherapy and salvage cystectomy in the treatment of invasive carcinoma of the bladder. In: Oliver RTD, Hendry WF, Bloom HJG (eds) Bladder cancer — Principles of combination therapy. Butterworths, London, pp 127–138
Johnson RK, Zee-Cheng RKY, Lee WW, Acton FM, Henry DW, Cheng CC (1979) Experimental antitumor activity of aminoanthraquinones. Cancer Treat Rep 63: 425–539
Kedia KR, Gibbons C, Persky L (1981) The management of advanced bladder carcinoma. J Urol 125: 655–658
Levi JA, Aroney RS, Dalley DN (1980) Combination chemotherapy with cyclophosphamide doxorubicin, and bleomycin for metastatic transitional cell carcinoma of the urinary tract. Cancer Treat Rep 64: 1011–1013
Martino S, Samal B, Al-Saraff M (1980) Phase II study of 5-fluorouracil and Adriamycin in transitional cell carcinoma of the urinary tract. Cancer Treat Rep 64: 161–163
Merrin C, Cartagena R, Wajsman Z, Baumgartner G, Murphy GP (1975) Chemotherapy of bladder cancer with cyclophosphamide and Adriamycin. J Urol 114: 884–887
Miller LS (1977) Bladder cancer: Superiority of preoperative irradiation therapy and cystectomy in clinical stages B2 and C. Cancer 39: 973–980
Mulder JH, Fossa SD, De Pauw M, Van Oosterom AT (1982) Cyclophosphamide, Adriamycin and cisplatin combination chemotherapy in advanced bladder carcinoma: An EORTC phase II study. Eur J Cancer Clin Oncol 18: 111–112
Murphy GP (1975) The current status of bladder cancer. In: Nyhus LM (ed) Surgery annual, vol 7. Appleton-Century Crofts, New York, pp 175–218
Natale RB, Yagoda A, Watson RC, Whitmore WF, Blumenreich M, Braun DW Jr (1981) Methotrexate — an active drug in bladder cancer. Cancer 47: 1246–1250
O'Bryan RM, Baker LH, Gottlieb JE, Riukin SE, Balcerzak SP, Grumet GN, Salmon SE, Moon TE, Hoogstraten B (1977) Dose response evaluation of Adriamycin in human neoplasm. Cancer 39: 1940–1948
Paulson DF, Perez CA, Anderson T (1981) Genito-urinary malignancies. In: De Vita VT Jr, Hellman S, Rosenberg S (eds) Cancer — Principles and practice of oncology. Lippincott, Philadelphia Toronto, pp 745–753
Peters PC, O'Neill MR (1980) cis-Diamminedichloroplatinum as a therapeutic agent in metastatic transitional cell carcinoma. J Urol 123: 375–377
Prout GR Jr, Griffin PP, Shipley WU (1979) Bladder carcinoma as a systemic disease. Cancer 43: 2532–2539
Rodriguez LH, Johnson DE, Holoye PY, Samuels ML (1977) Combination of VM-26 and Adriamycin for metastatic transitional cell carcinoma. Cancer Treat Rep 61: 87–88
Skinner DG (1980) Current perspectives in the management of high-grade invasive bladder cancer. Cancer 45: 1866–1874
Smith JA, Whitmore WF (1981) Regional lymph node metastasis from bladder cancer. J Urol 126: 591–593
Smith PH (1983) Invasive bladder cancer — A lethal enigma. In: Smith PH, Prout GR (eds) Bladder cancer. Butterworths, London (in press)
Soloway MS, Ikard M, Ford K (1981) cis-Diamminedichloroplatinum (II) in locally advanced and metastatic urothelial cancer. Cancer 47: 467–480
Stephens RL, Clark G (1981) Phase II with mitoxantrone in non-hematologic malignancies. NCI-EORTC Symposium on New Drugs, Abstract 36
Sternberg JJ, Bracken RB, Handel PB, Johnson DE (1977) Combination chemotherapy (CISCA) for advanced urinary tract carcinoma. A preliminary report. JAMA 238: 2282–2287
Stoter G (1982) Chemotherapy of advanced bladder cancer. Abstracts of the European Society for Therapeutic Radiology and Oncology 70
Troner MB, Hemstreet GP III (1981) Cyclophosphamide, doxorubicin, and cisplatin (CAP) in the treatment of urothelial malignancy: A pilot study of the Southeastern Cancer Study Group. Cancer Treat Rep 65: 29–32
Turner AG, Hendry WF, Williams GB, Bloom HJG (1977) The treatment of advanced bladder cancer with methotrexate. Br J Urol 49: 673–678
Veenema RJ, Harisiadis L, Chang C, Puchner P, Romas N, Wechsler M, Guttman R (1981) Bladder carcinoma: Preliminary external radiotherapy used as a means for selecting complete treatment. In: Connolly JG (ed) Carcinoma of the bladder. Raven Press, New York, pp 183–191
Von Hoff DD, Pollard E, Kuhn J, Murray E, Coltman CA Jr (1980) Phase I clinical investigation of 1,4-dihydroxy-5,8-bis[a2-(2-hydroxyethyl)amino (ethyl amino)]-9,10-anthracenedione dihydrochloride (NSC 301739), a new anthracenedione. Cancer Res 40: 1516
Wallace DM, Bloom HJG (1976) The management of deeply infiltrating (T3) bladder carcinoma: controlled trial of radical radiotherapy vs pre-operative radiotherapy and radical cystectomy (first report). Br J Urol 48: 587–594
Wallace RE, Murdock KC, Angier RB, Durr FE (1979) Activity of a novel anthracenedione, 1,4-dihydroxy-5,8bis(((2-2-hydroxyethyl) aminoethylamino))-9,10-anthracenedione dihydrochloride, against experimental tumors in mice. Cancer Res 39: 1570–1574
Weinstein SH, Schmidt JD (1976) Doxorubicin chemotherapy in advanced transitional cell carcinoma. Urology 8: 336–341
Werf-Messing B van der (1981) Combined-modality treatment of bladder cancer at the Rotterdam Radiotherapy Institute. In: Connolly JG (ed) Carcinoma of the bladder. Raven Press, New York, pp 219–226
Whitmore WF Jr (1981a) Integrated irradiation and cystectomy for bladder cancer. In: Connolly JG (ed) Carcinoma of the bladder. Raven Press, New York, pp 235–249
Whitmore WF Jr (1981b) Pre-operative low-dose radiotherapy and cystectomy. In: Oliver RTD, Hendry WF, Bloom HJG (eds) Bladder cancer — Principles of combinaton therapy. Butterworths, London, pp 175–182
Williams G, Jones MA, Trott PA, Bloom HJG (1981) Carcinoma of the bladder treated by local interstitial irradiation. In: Oliver RTD, Hendry WF, Bloom HJG (eds) Bladder cancer — Principles of combination therapy. Butterworths, London, pp 117–126
Williams SD, Donohue JP, Einhorn LH (1979) Advanced bladder cancer: Therapy with cis-dichlorodiammineplatinum (II), Adriamycin, and 5-fluorouracil. Cancer Treat Rep 63: 1573–1576
Wizenberg NJ (1979) Invasive bladder cancer — Definitive irradiation and salvage cystectomy. Semin Oncol 6: 229–235
Yagoda A (1977) Future implications of phase 2 chemotherapy trials in ninety-five patients with measurable advanced bladder cancer. Cancer Res 37: 2775–2780
Yagoda A, Watson RC, Kemeny N, Barzell WE, Grabstald H, Whitmore WF (1978) Diamminedichloride platinum II and cyclophosphamide in the treatment of advanced urothelial cancer. Cancer 41: 2121–2130
Zee-Cheng RKY, Cheng CC (1978) Antineoplastic agents. Structure activity relationship study of bis (substituted aminoalkylamino) anthraquinones. J Med Chem 21: 291–294
Zingg EJ, Zeltner T (1980) Partial cystectomy. In: Pavone-Macaluso M, Smith PH, Edsmyr F (eds) Bladder tumors and other topics in urological oncology. Plenum Press, London New York, pp 201–205
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Smith, P.H., Child, J.A., Mulder, J.H. et al. Cooperative studies of systemic chemotherapy. Cancer Chemother. Pharmacol. 11 (Suppl 1), S25–S31 (1983). https://doi.org/10.1007/BF00256713
Issue Date:
DOI: https://doi.org/10.1007/BF00256713